4th Quarter - Termination

NVG, LLC for GLOBAL BLOOD THERAPEUTICS

Firm
Client
Income
$50,000
Expenses
—
Terminated
Dec 31, 2022

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 20, 2023 $50,000 Replaced
4th Quarter - Termination (this page) Apr 10, 2023 $50,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R.8855/S.4866 - Sickle Cell Disease Treatment Centers Act of 2022.

LobbyistCovered position, as disclosed
IRENE BUENO —
LISA GERMAN FOSTER —
EDEN SHIFERAW —

Contacted: Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 4866 (117th), H.R. 8855 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.